Prompt diagnosis and treatment of infantile epileptic spasms syndrome, a severe seizure disorder beginning in infancy, can prevent developmental delays. But non-Hispanic Black children are less likely ...

LOS ANGELES — Artificial intelligence (AI) analysis of caregiver-recorded videos has the potential to diagnose infantile epileptic spasm syndrome, according to a new study. Infants with the condition ...

A groundbreaking study has found the underlying cause and a potential treatment for infantile spasms -- intractable epilepsy common in babies and with limited treatment options. Infantile spasm (IS) ...

Infantile spasm (IS) is a severe epileptic syndrome of infancy and accounts for 50% of all epilepsy cases that occur in babies during the first year of life. Current treatment options for this ...

Infantile spasms represent a severe epileptic encephalopathy predominantly affecting early childhood, with West syndrome constituting a well‐defined clinical subset marked by a triad of spasms, ...

BANGALORE, Oct 15 (Reuters) - Questcor Pharmaceuticals Inc said the U.S. health regulator approved its Acthar gel to treat seizures in infants, sending its shares up as much as 10 percent. Sign up ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted final approval to Zydus for Sabril, an anticonvulsant used to treat children aged 1 month to ...

Researchers report that infantile spasms, a rare but serious seizure disorder in babies, appear to be the result of a molecular pathway gone awry. In their study of a mouse model of the disorder, the ...

Credit: Pyros Pharmaceuticals. The prescribing information for Vigpoder carries a Boxed Warning associated with a risk for permanent vision loss. Vigpoder ™ (vigabatrin) for oral solution has been ...

When Faustina Cavero, 31, first saw her baby make an odd gesture, she thought she must have scared her when picking her up. The nearly 5-month-old's arms would stretch and stiffen. She made faces like ...

Infantile spasm (IS) is a severe epileptic syndrome of infancy and accounts for 50% of all epilepsy cases that occur in babies during the first year of life. Current treatment options for this ...